These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23209232)

  • 21. Nosocomial outbreak of a multiresistant Acinetobacter baumannii expressing OXA-23 carbapenemase in Spain.
    Merino M; Poza M; Roca I; Barba MJ; Sousa MD; Vila J; Bou G
    Microb Drug Resist; 2014 Aug; 20(4):259-63. PubMed ID: 24328852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multidrug-resistant Acinetobacter baumannii infection in children.
    De Luca M; Angelino G; Calò Carducci FI; Martino A; Bernardi S; Bernaschi P; Carletti M; D'Argenio P; Palma P
    BMJ Case Rep; 2011 Aug; 2011():. PubMed ID: 22688471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The efficacy of the tigecycline-colistin association in the treatment of multi-resistant Acinetobacter baumannii meningitis].
    Regaieg K; Bahloul M; Turki O; Mnif B; Bouaziz M
    Med Mal Infect; 2017 Mar; 47(2):175-177. PubMed ID: 28215823
    [No Abstract]   [Full Text] [Related]  

  • 24. Changes in MIC within a global collection of Acinetobacter baumannii collected as part of the Tigecycline Evaluation and Surveillance Trial, 2004 to 2009.
    Morfin-Otero R; Dowzicky MJ
    Clin Ther; 2012 Jan; 34(1):101-12. PubMed ID: 22177546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidrug-resistant Acinetobacter baumannii bacteremia treated with tigecycline in two pediatric burn patients.
    Kanık-Yüksek S; Tezer H; Ozkaya-Parlakay A; Gulhan B; Sayed-Oskovi H; Kara A; Şenel E
    Pediatr Infect Dis J; 2015 Jun; 34(6):677. PubMed ID: 25970113
    [No Abstract]   [Full Text] [Related]  

  • 26. Tigecycline treatment in an infant with extensively drug-resistant Acinetobacter baumannii bacteremia.
    Zeng J; Zhang L; Gao M; Wu J; Wu H; Chen J; Chen X; Tang W
    Int J Infect Dis; 2017 Aug; 61():23-26. PubMed ID: 28572073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pharmacodynamic simulation to evaluate tigecycline in treatment of nosocomial pneumonia caused by multidrug-resistant Acinetobacter baumannii.
    Ni WT; Liang BB; Cai Y; Liu YP; Bai N; Cui JC; Wang R
    Pak J Pharm Sci; 2014 May; 27(3):463-7. PubMed ID: 24811802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic considerations regarding tigecycline for multidrug-resistant (MDR) Klebsiella pneumoniae or MDR Acinetobacter baumannii urosepsis.
    Cunha BA
    J Clin Microbiol; 2009 May; 47(5):1613. PubMed ID: 19403778
    [No Abstract]   [Full Text] [Related]  

  • 29. Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii.
    Schafer JJ; Goff DA; Stevenson KB; Mangino JE
    Pharmacotherapy; 2007 Jul; 27(7):980-7. PubMed ID: 17594203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii isolates in a university hospital in Nepal reveals the emergence of a novel epidemic clonal lineage.
    Shrestha S; Tada T; Miyoshi-Akiyama T; Ohara H; Shimada K; Satou K; Teruya K; Nakano K; Shiroma A; Sherchand JB; Rijal BP; Hirano T; Kirikae T; Pokhrel BM
    Int J Antimicrob Agents; 2015 Nov; 46(5):526-31. PubMed ID: 26362951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multidrug-resistant Acinetobacter baumannii osteomyelitis from Iraq.
    Schafer JJ; Mangino JE
    Emerg Infect Dis; 2008 Mar; 14(3):512-4. PubMed ID: 18325278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tigecycline in carbapenem-resistant Acinetobacter baumannii bacteraemia: susceptibility and clinical outcome.
    Kim NH; Hwang JH; Song KH; Choe PG; Kim ES; Park SW; Kim HB; Kim NJ; Park WB; Oh MD
    Scand J Infect Dis; 2013 Apr; 45(4):315-9. PubMed ID: 23113680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tigecycline treatment experience against multidrug-resistant Acinetobacter baumannii infections: a systematic review and meta-analysis.
    Ni W; Han Y; Zhao J; Wei C; Cui J; Wang R; Liu Y
    Int J Antimicrob Agents; 2016 Feb; 47(2):107-16. PubMed ID: 26742726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. OXA-type Carbapenemases and Susceptibility of Colistin and Tigecycline Among Carbapenem-Resistant Acinetobacter Baumannii Isolates from Patients with Bacteremia in Turkey.
    Cakirlar FK; Ciftci IH; Gonullu N
    Clin Lab; 2015; 61(7):741-7. PubMed ID: 26299073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.
    Navon-Venezia S; Leavitt A; Carmeli Y
    J Antimicrob Chemother; 2007 Apr; 59(4):772-4. PubMed ID: 17353223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
    Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
    J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minocycline and Tigecycline: What Is Their Role in the Treatment of Carbapenem-Resistant Gram-Negative Organisms?
    Shankar C; Nabarro LEB; Anandan S; Veeraraghavan B
    Microb Drug Resist; 2017 Jun; 23(4):437-446. PubMed ID: 27564414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of insertion sequence Aba-1 and AdeS in reduced tigecycline susceptibility in MDR-Acinetobacter baumannii clinical isolates from Cairo, Egypt.
    Hassan R; Mukhtar A; Hasanin A; Ghaith D
    J Chemother; 2018 Apr; 30(2):89-94. PubMed ID: 29108486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome sequence of a dominant, multidrug-resistant Acinetobacter baumannii strain, TCDC-AB0715.
    Chen CC; Lin YC; Sheng WH; Chen YC; Chang SC; Hsia KC; Liao MH; Li SY
    J Bacteriol; 2011 May; 193(9):2361-2. PubMed ID: 21398540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of tigecycline resistance development in clinical Acinetobacter baumannii isolates through a combined genomic and transcriptomic approach.
    Liu L; Cui Y; Zheng B; Jiang S; Yu W; Shen P; Ji J; Li L; Qin N; Xiao Y
    Sci Rep; 2016 May; 6():26930. PubMed ID: 27240484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.